error fb Gplus IN twitter down-arrow Email Phone Check-Mark padlock circle_arrow minus plus play_btn close Clipboard_Icon Shopping-Cart_Icon Speech_Bubble_Icon Stethoscope_Icon pharmacists menu left-arrow right-arrow facebook search cart
 

The Dexcom G6 CGM System.
Technology that lets us manage diabetes without fingersticks.*

* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Meet the Dexcom G6.

A small, wearable continuously sends glucose readings to your smartphone or Dexcom receiver - without fingersticks.*

 

* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Easy to Use

The Dexcom G6 is a small, discreet wearable that you apply yourself and lasts up to 10 days.

Goodbye, Fingersticks

Glance at your smartphone. See your glucose. Make diabetes treatment decisions. All without fingersticks.*

 

* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Lowers A1C

Using a Dexcom CGM is proven to lower A1C and help you spend more time in range.1,2

“I struggled to lower my A1C until I got the Dexcom G6. Now it’s so much easier to stay on top of my glucose. My A1C is down 3 points.”§

Harrel C., Age 52
Dexcom Warrior
Individual results may vary.

“I want all my Type 2 patients who depend on insulin to be on the Dexcom G6.”

Dr. Michael Heile, T1D

Endocrinologist

Paid spokesperson of Dexcom, Inc.

Get started with Dexcom today.

We’ve made the prescription process easy for your healthcare professional: Please fill out the form below to get started.

Please fill out the information below to help us determine if the Dexcom CGM is right for you or your loved one. A customer service representative of Dexcom, or a service provider on behalf of Dexcom, may follow up with you to process a full insurance benefits check or to discuss other Dexcom products, services or programs, after reviewing your information.

All fields marked with an asterisk (*) are required.

Personal Information

Therapy Coverage Information

Doctor & Insurance Provider Information

By clicking “Next” and submitting this form, you agree to the terms and conditions of the Terms of Use and Privacy Policy, and agree that we may use information provided to us to communicate with you in accordance with those terms. You agree that Dexcom or a service provider on behalf of Dexcom, may contact you at the phone number set forth above, and Dexcom or its service provider may use automatic dialing machines. In addition, you certify that you (i) are the patient referenced above or (ii) are the parent or legal guardian of the patient referenced above, and that you are at least eighteen (18) years of age. Dexcom may use your information to communicate with you about Dexcom products, services and programs that may be of interest to you, or to provide you with information relating to your healthcare treatment, payment for healthcare, or other health information or care coordination services.

Dexcom engages third party service providers to perform certain services on our behalf. Pursuant to our Privacy Policy, we may share your information with one or more of our service providers in order to help assess whether the Dexcom CGM is appropriate for you or your loved one. Dexcom and its service provider may contact you in a number of ways. Your consent to this contact is not required for purchase of Dexcom products or services. You may contact Dexcom at the number below at any time to obtain additional information or to opt-out of receiving telephone calls. Your service provider's airtime, message and data rates may apply.

By clicking "Next" and submitting this form, you agree to the terms and conditions of the Terms of Use and Privacy Policy, and agree that we may use information provided to us to communicate with you in accordance with those terms. In addition, you certify that you (i) are the patient referenced above or (ii) are the parent or legal guardian of the patient referenced above, and that you are at least eighteen (18) years of age. Dexcom may use your information to communicate with you about Dexcom products, services and programs that may be of interest to you, or to provide you with information relating to your healthcare treatment, payment for healthcare, or other health information or care coordination services.

Dexcom engages third party service providers to perform certain services on our behalf. Pursuant to our Privacy Policy, we may share your information with one or more of our service providers in order to help assess whether the Dexcom CGM is appropriate for you or your loved one. Dexcom and its service provider may contact you in a number of ways. You agree that Dexcom, or a service provider on behalf of Dexcom, may send SMS/text messages or call you at 888-738-3646, and may use automatic dialing machines and automated, pre-recorded voice messages. You may opt out at any time by texting "STOP" in return to a text or by calling Dexcom at the number set forth above. Your consent to this contact is not required for purchase of Dexcom products or services. You may contact Dexcom at the number below at any time to obtain additional information or to opt-out of receiving telephone calls. Your service provider's airtime, message and data rates may apply.

"Dexcom does give me confidence to do whatever I want, go wherever I want and be the person that I am."
- Dexcom warrior, Stephanie – T1D
Have Questions?
Our customer support representatives are available to help answer your questions at 888-738-3646.

* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

† For a list of compatible devices, visit http://www.Dexcom.com/compatibility. Stable internet connection required.

‡ See user guide for set up instructions

§ Based upon a customer's experience; individual results may vary. Randomized controlled trial and real-world data indicate that Dexcom CGM use results in a mean A1C reduction of 0.8%  (Beck RW et al. Ann Intern Med 2017;167(6):365-74) and 1.5% (Noar A, et al. Presented at ADA 80th Scientific Sessions; June 12, 2020; Virtual) respectively, from baseline for patients with T2D. 

1 Beck, RW. JAMA. 2017; 317(4); 371-378.

2 Welsh JB, et al. Diabetes Technol Ther 2019;21(3):128-32.

 

BRIEF SAFETY STATEMENT: Available by prescription only. Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www. dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. © 2020 Dexcom Inc. All rights reserved. This product is covered by U.S. patent.